Latest News on HQY

Financial News Based On Company


Advertisement
Advertisement

Reasons to Add HealthEquity Stock to Your Portfolio for Now

https://www.zacks.com/stock/news/2793587/reasons-to-add-healthequity-stock-to-your-portfolio-for-now
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.

What Does the Market Think About HealthEquity Inc? - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/insights/short-sellers/25/11/48927754/what-does-the-market-think-about-healthequity-inc
HealthEquity Inc's ( NYSE:HQY ) short interest as a percent of float has risen 4.42% since its last report. According to exchange reported data, there are now 4.42 million shares sold short, which is 5.91% of all regular shares that are available for trading.

LifeMD, Inc. ( LFMD ) Reports Q3 Loss, Misses Revenue Estimates

https://www.zacks.com/stock/news/2792177/lifemd-inc-lfmd-reports-q3-loss-misses-revenue-estimates
LifeMD (LFMD) delivered earnings and revenue surprises of -66.67% and -3.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

PGNY vs. HQY: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2791421/pgny-vs-hqy-which-stock-is-the-better-value-option
Investors interested in stocks from the Medical Services sector have probably already heard of Progyny ( PGNY Quick QuotePGNY - ) and HealthEquity ( HQY Quick QuoteHQY - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience

https://www.zacks.com/stock/news/2791087/healthequity-rolls-out-agentic-ai-to-elevate-member-support-experience
HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.
Advertisement

BDX Unveils Portable PureWick System for On-the-Go Incontinence Care

https://www.zacks.com/stock/news/2790858/bdx-unveils-portable-purewick-system-for-on-the-go-incontinence-care
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.

STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics

https://www.zacks.com/stock/news/2790857/stxs-secures-fda-approval-for-genesisx-to-broaden-surgical-robotics
Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.

Synergy CHC Corp. ( SNYR ) Meets Q3 Earnings Estimates

https://www.zacks.com/stock/news/2790474/synergy-chc-corp-snyr-meets-q3-earnings-estimates
Synergy CHC Corp. (SNYR) delivered earnings and revenue surprises of 0.00% and -26.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold DexCom Stock in Your Portfolio for Now

https://www.zacks.com/stock/news/2789529/heres-why-you-should-hold-dexcom-stock-in-your-portfolio-for-now
DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.

Why HealthEquity ( HQY ) is a Top Growth Stock for the Long-Term

https://www.zacks.com/stock/news/2784630/why-healthequity-hqy-is-a-top-growth-stock-for-the-long-term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Advertisement

DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised

https://www.zacks.com/stock/news/2782885/dexcom-stock-falls-despite-q3-earnings-beat-2025-revenue-view-raised
DXCM posts double-digit Q3 growth and raises 2025 revenue outlook, but shares tumble despite strong CGM momentum and innovation updates.

Alignment ( ALHC ) Q3 2025 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2025/10/31/alignment-alhc-q3-2025-earnings-call-transcript/
Image source: The Motley Fool.Thursday, October 30, 2025 at 5 p.m. ETChief Executive Officer - John KaoContinue reading ...

Avantor Stock Plunges as Q3 Earnings Miss Estimates, Revenues Down Y/Y

https://www.zacks.com/stock/news/2781907/avantor-stock-plunges-as-q3-earnings-miss-estimates-revenues-down-yy
AVTR's Q3 earnings and revenue fell short of estimates, leading the company to cut its full-year 2025 outlook.

DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y

https://www.zacks.com/stock/news/2781899/davita-stock-down-post-q3-earnings-miss-estimates-revenues-up-yy
DVA's Q3 earnings miss estimates despite revenue growth, as margins tightened and shares slipped post-results.

TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

https://www.zacks.com/stock/news/2781897/tmdx-stock-falls-despite-q3-earnings-beat-estimates-revenues-up-yy
TransMedics posts surging profit and higher revenues on strong OCS and logistics growth, yet its shares slide despite upbeat Q3 results.
Advertisement

OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands

https://www.zacks.com/stock/news/2781814/opk-q3-earnings-beat-estimates-sales-miss-gross-margin-expands
OPKO Health's Q3 earnings top estimates despite lower sales. Cost cuts and product strength boost margins and operating income.

GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised

https://www.zacks.com/stock/news/2781810/gkos-stock-surges-following-q3-earnings-revenue-beat-guidance-raised
Glaukos reported a narrower Q3 loss, strong 38% sales jump, and raised 2025 outlook as iDose TR and Epioxa fuel momentum across key franchises.

BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down

https://www.zacks.com/stock/news/2781672/bax-stock-falls-following-q3-earnings-beat-sales-miss-25-eps-view-down
Baxter's Q3 earnings top forecasts, but sales lag and 2025 EPS guidance slips. shares fall despite strength in Pharma and Advanced Surgery.

CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains

https://www.zacks.com/stock/news/2781669/cah-q1-earnings-beat-estimates-26-eps-view-up-stock-gains
Cardinal Health delivered a strong Q1 beat and lifted its 2026 EPS outlook, fueled by broad-based growth and rising profits across all business segments.

GE HealthCare Q3 Earnings and Revenues Beat Estimates, Net Margin Falls

https://www.zacks.com/stock/news/2779927/ge-healthcare-q3-earnings-and-revenues-beat-estimates-net-margin-falls
GE HealthCare's Q3 results show steady revenue growth as strong imaging and diagnostics offset tariff and margin pressures.
Advertisement

ECL Stock Falls in Pre-Market Despite Q3 Earnings Beat, Margins Expand

https://www.zacks.com/stock/news/2779408/ecl-stock-falls-in-pre-market-despite-q3-earnings-beat-margins-expand
Ecolab tops third-quarter 2025 estimates with strong margin gains and lifts full-year EPS outlook amid steady segment growth.

HCA Healthcare, Inc. ( HCA ) Hit a 52 Week High, Can the Run Continue?

https://www.zacks.com/stock/news/2778827/hca-healthcare-inc-hca-hit-a-52-week-high-can-the-run-continue
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

How Do Investors Really Feel About HealthEquity Inc? - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/insights/short-sellers/25/10/48440780/how-do-investors-really-feel-about-healthequity-inc
HealthEquity Inc's ( NYSE:HQY ) short interest as a percent of float has fallen 16.76% since its last report. According to exchange reported data, there are now 4.24 million shares sold short, which is 5.66% of all regular shares that are available for trading.

RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised

https://www.zacks.com/stock/news/2777916/rvty-q3-earnings-beat-sales-in-line-25-eps-view-raised
Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.

CVS or HQY: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2773319/cvs-or-hqy-which-is-the-better-value-stock-right-now
CVS vs. HQY: Which Stock Is the Better Value Option?
Advertisement

HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms

https://www.zacks.com/stock/news/2772371/hqy-expands-access-with-glp-1-telehealth-direct-hsa-platforms
HealthEquity rolls out GLP-1 telehealth and direct HSA enrollment platforms, targeting affordability and growth amid rising healthcare costs and regulatory expansion.

Here's Why HealthEquity ( HQY ) is a Strong Growth Stock

https://www.zacks.com/stock/news/2771151/heres-why-healthequity-hqy-is-a-strong-growth-stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Reasons to Add HealthEquity Stock to Your Portfolio for Now

https://www.zacks.com/stock/news/2770497/reasons-to-add-healthequity-stock-to-your-portfolio-for-now
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.

HealthEquity Introduces GLP-1 Telehealth and Direct HSA Enrollment Platforms - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/pressreleases/25/10/g48194772/healthequity-introduces-glp-1-telehealth-and-direct-hsa-enrollment-platforms
DRAPER, Utah, Oct. 14, 2025 ( GLOBE NEWSWIRE ) -- HealthEquity, Inc. ( NASDAQ:HQY ) , the nation's largest Health Savings Accounts ( HSAs ) and consumer-directed benefits administrator, today announced two consumer-focused initiatives designed to expand access to affordable healthcare solutions ...

HealthEquity EVP Sold $157K In Company Stock - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/insights/news/25/10/48127599/healthequity-evp-sold-157k-in-company-stock
A substantial insider sell was reported on October 8, by Henry Michael Fiore, EVP at HealthEquity ( NASDAQ:HQY ) , based on the recent SEC filing. What Happened: Fiore opted to sell 1,781 shares of HealthEquity, according to a Form 4 filing with the U.S. Securities and Exchange Commission on ...
Advertisement

HealthEquity ( HQY ) Down 5.1% Since Last Earnings Report: Can It Rebound?

https://www.zacks.com/stock/news/2760921/healthequity-hqy-down-51-since-last-earnings-report-can-it-rebound
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

How Do Investors Really Feel About HealthEquity Inc? - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/insights/short-sellers/25/09/47942211/how-do-investors-really-feel-about-healthequity-inc
HealthEquity Inc's ( NYSE:HQY ) short interest as a percent of float has fallen 12.09% since its last report. According to exchange reported data, there are now 4.41 million shares sold short, which is 5.89% of all regular shares that are available for trading.

Why HealthEquity ( HQY ) is a Top Growth Stock for the Long-Term

https://www.zacks.com/stock/news/2757733/why-healthequity-hqy-is-a-top-growth-stock-for-the-long-term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

https://www.globenewswire.com/news-release/2025/09/25/3156338/32142/en/HealthEquity-Strengthens-Executive-Leadership-Team-with-Strategic-Appointments-to-Drive-Growth-and-Innovation.html
New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion ...

Why HealthEquity ( HQY ) is a Top Momentum Stock for the Long-Term

https://www.zacks.com/stock/news/2755692/why-healthequity-hqy-is-a-top-momentum-stock-for-the-long-term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Advertisement

Why HealthEquity ( HQY ) is a Top Growth Stock for the Long-Term

https://www.zacks.com/stock/news/2748728/why-healthequity-hqy-is-a-top-growth-stock-for-the-long-term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y

https://www.zacks.com/stock/news/2746936/healthequity-stock-gains-as-q2-earnings-beat-estimates-revenues-up-yy
HQY's Q2 results reflect EPS growth of 25.6% year over year, revenue growth of 8.6% and a 12% increase in HSA. The company also updates its fiscal 2026 guidance.

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Cogent Biosciences ( NASDAQ:COGT ) , Alkermes ( NASDAQ:ALKS )

https://www.benzinga.com/news/25/09/47474541/macys-increases-fy2025-outlook-joins-rev-group-healthequity-alphabet-and-wellness-and-other-big-stocks-movin
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wednesday. Shares of Macy's, Inc. M rose sharply during Wednesday's session after the company reported second-quarter results above estimates and raised its FY2025 guidance.

HealthEquity Net Income Jumps 67% in Q2

https://www.fool.com/data-news/2025/09/03/healthequity-net-income-jumps-67-in-q2/
HealthEquity ( NASDAQ:HQY ) , a leading provider of Health Savings Account ( HSA ) custodial services in the United States, reported fiscal 2026 second-quarter earnings on Sept. 2. The release noted solid profit growth and improved margins, despite some deceleration in organic account expansion.

Stock Market Today: Nasdaq Futures Rise, Dow Slips Amid Mixed Trade-Google, Dollar Tree, Campbell's In Focus - SPDR S&P 500 ( ARCA:SPY )

https://www.benzinga.com/markets/equities/25/09/47467258/stock-market-today-nasdaq-futures-rise-dow-slips-amid-mixed-trade-google-dollar-tree-campbells-i
U.S. stock futures were fluctuating on Wednesday following Tuesday's declines. Futures of major benchmark indices were trading mixed. President Donald Trump signed an executive order targeting a fourfold increase in domestic nuclear power production over 25 years.
Advertisement

Dollar Tree, Campbell's And 3 Stocks To Watch Heading Into Wednesday - The Campbell's ( NASDAQ:CPB ) , Salesforce ( NYSE:CRM )

https://www.benzinga.com/markets/equities/25/09/47466205/dollar-tree-campbells-and-3-stocks-to-watch-heading-into-wednesday
With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Dollar Tree Inc. DLTR to report quarterly earnings at 40 cents per share on revenue of $4.48 billion before the opening bell, according to ...

HealthEquity ( HQY ) Q2 Earnings and Revenues Surpass Estimates

https://www.zacks.com/stock/news/2746341/healthequity-hqy-q2-earnings-and-revenues-surpass-estimates
HealthEquity (HQY) delivered earnings and revenue surprises of +17.39% and +2.20%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity Stock Climbs After Q2 Earnings Report: Here's Why - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/markets/earnings/25/09/47461445/healthequity-stock-climbs-after-q2-earnings-report-heres-why
HealthEquity reports adjusted earnings of $1.08 per share, which beat the Street estimate of 92 cents. Quarterly revenue comes in at $325.83 million, which beat the $320.82 million analyst estimate. Post-Labor Day Trading Could Trigger Major Market Moves. Here's How to Trade It HealthEquity, ...

HealthEquity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/analyst-stock-ratings/price-target/25/09/47443125/healthequity-earnings-are-imminent-these-most-accurate-analysts-revise-forecas
HealthEquity, Inc. HQY will release earnings results for the second quarter after the closing bell on Tuesday, Sept. 2. Analysts expect the Draper, Utah-based company to report quarterly earnings at 92 cents per share, up from 86 cents per share in the year-ago period.

HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/pressreleases/25/08/g47416015/healthequitys-ai-powered-tool-recognized-for-innovation-in-streamlining-benefits-education
DRAPER, Utah, Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- HealthEquity, Inc.
Advertisement

HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education

https://www.globenewswire.com/news-release/2025/08/29/3141641/32142/en/HealthEquity-s-AI-Powered-Tool-Recognized-for-Innovation-in-Streamlining-Benefits-Education.html
Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For ...

CVS vs. HQY: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2743648/cvs-vs-hqy-which-stock-is-the-better-value-option
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health ( CVS Quick QuoteCVS - ) and HealthEquity ( HQY Quick QuoteHQY - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.

Countdown to HealthEquity ( HQY ) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

https://www.zacks.com/stock/news/2743344/countdown-to-healthequity-hqy-q2-earnings-a-look-at-estimates-beyond-revenue-and-eps
Get a deeper insight into the potential performance of HealthEquity (HQY) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

What's Driving the Market Sentiment Around HealthEquity? - HealthEquity ( NASDAQ:HQY )

https://www.benzinga.com/insights/short-sellers/25/08/47342763/whats-driving-the-market-sentiment-around-healthequity
HealthEquity's HQY short percent of float has fallen 11.57% since its last report. The company recently reported that it has 4.80 million shares sold short, which is 6.42% of all regular shares that are available for trading.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

https://www.zacks.com/stock/news/2740217/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement